Clinical
LUMINA trial tests manganese-based MRI contrast alternative
The phase 2/3 trial is evaluating mangaciclanol, GE HealthCare’s investigational manganese-based MRI contrast agent.
Section
All News
Every story we've published, newest first. 296 articles.
Business
MR-guided cardiac mapping platform reaches U.S. market
NorthStar is a cardiac mapping and guidance platform designed for real-time MR-guided interventional procedures.
Business
Ionetix funding backs isotope scale-up after public-market move
The Lansing, MI-based particle accelerator company also completed a reverse merger with JDEV Acquisition.
Clinical
Routine chest X-ray measure may predict lung surgery outcomes
Researchers found that lower preoperative diaphragmatic dome height on chest X-rays was associated with poorer 3-year survival after lung cancer surgery. The measurement may offer a low-cost way to identify higher-risk patients before lobectomy.
Business
CathWorks deal gives Medtronic AI-based coronary FFR tool
The $585M deal adds CathWorks’ FFRangio system to Medtronic’s interventional cardiology portfolio.
Business
NYU-Bracco pact targets AI and advanced imaging research
The multiyear agreement will focus on MRI, photon-counting CT, targeted ultrasound, and AI-enabled PET/CT and MRI image analysis.
Business
Nanox.ARC distribution push targets 300 U.S. systems
Relevant. Nanox.ARC is an FDA-cleared multisource digital tomosynthesis system intended to expand 3D imaging access across healthcare and public sector settings.
Business
Sectra adds autonomous chest X-ray AI through Oxipit acquisition
The deal gives Sectra ownership of ChestLink, Oxipit’s CE Class IIb-certified autonomous AI product for chest X-ray analysis.
AI & Imaging
GE-DeepHealth deal adds second-reader tools to breast AI
The expanded collaboration adds DeepHealth Breast Suite applications to GE HealthCare mammography systems, including Pristina Via.
Business
LucidHealth leadership shift follows teleradiology rebrand
Grau will become CEO on May 1, with Steve Corbeil moving to executive chairman of the board as part of a planned succession.